Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_assertion type Assertion NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_head.
- NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_assertion description "[The EphA2 tyrosine kinase receptor is frequently overexpressed in ovarian cancer and this feature is predictive of poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_provenance.
- NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_assertion evidence source_evidence_literature NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_provenance.
- NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_assertion SIO_000772 16969087 NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_provenance.
- NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_assertion wasDerivedFrom befree-20150227 NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_provenance.
- NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_assertion wasGeneratedBy ECO_0000203 NP600077.RAU-8I1WK5j56MpLcLXdv-Gq-VC12yM9K0HyLCJ0vQJDY130_provenance.